News

Dr. Kim on the Future Role of Y-90 in Patients with Unresectable HCC

OncLive

New York, NY
(June 29, 2022)

Edward Kim, MD, discusses the future role of Y-90 in patients with unresectable hepatocellular carcinoma.

Tags: Mount Sinai Health System, Radiology, Edward Kim, MD

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts